AWAITING THE OPERATION of Equifund II with an initial budget of €200 million which is aimed at micro, small, medium-companies as well as mid-caps, at all stages of their development.


Equifund II is a separate "fund of funds" like EATE, for example, which operates financing tools for Venture Capitals. Specifically, the funding concerns Technology Transfer projects in thematic sections that were further specialized for the Life and Health Sectors and Sustainable Development and Social Innovation/Entrepreneurship:

biotech, pharmaceutical, medical device business ventures

groups that aim to create measurable social benefit (including solutions to social and/or environmental problems) for specific social groups or the society, while generating financial benefit for investors


In particular, the Fund aims to improve the market conditions for investments in companies by providing venture capital (Venture Capital and Private Equity Funds), in cooperation and with co-investment from selected Intermediary Financial Organizations and private investors. The agreement for the new financial tool EquiFund II implemented through the Program "Competitiveness 2021-2027", was signed by the Deputy Minister of National Economy & Finance, Nikos Papathanasis, the Vice-President of the European Investment Fund of the EIB, Ioannis Tsakiris and the Managing Director of the EIB , Marjut Falkstedt.

Equifund II is an act of strategic importance for the Competitiveness Program and is co-financed by the European Regional Development Fund (ERDF) of the European Union.